focus -WSS

focus

author：entertainment 2025-09-29 17:02:20 - browse：17

Outgoing Bristol CEO Giovanni Caforio Emilie Pickering for STAT

It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO Giovanni Caforio will step down. He’ll be replaced by Christopher Boerner, who is currently chief operating officer.

When Caforio took over in May 2015, Bristol was known as a big pharmaceutical firm with the high-flying stock of a biotechnology company, largely due to its role as the company that brought cancer immunotherapy to market. But Bristol stumbled in 2016 when its immunotherapy Opdivo failed to help patients with non-small cell cancer more than chemotherapy. Opdivo remained a big seller, but its failure allowed Merck’s rival Keytruda to move into position to become the best-selling medicine in the world. In 2019, Caforio tried to flip the script, buying the biotech Celgene for $74 billion.

STAT recently sat down with Caforio, 59, to look back on what went wrong and right with his tenure. He also reflected on what it meant to be a physician — and the son of a physician. “We were speaking about patient stories over lunch and dinner, when I was a kid, and I think that drove my passion for medicine,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： How artificial intelligence is being used to detect, treat cancer

leisure time

WSS

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Elizabeth Warren probes abortion access

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Poland's lawmakers approve a divisive law on Russian influence

focus

focus

hotspot

The high cost of giving birth even with insurance

HCA says smaller share of spending going to labor

How one medical school became remarkably diverse

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Malaria cases in Florida and Texas: Here’s what you need to know

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Jerome Adams on the need for new antivirals for Covid

Providers still hesitate to prescribe buprenorphine, study finds

Medicare details structure of new drug price negotiation program

Caitlin Bernard's story shows physicians can't shy from advocacy

knowledge

Teacher posts viral 'school supply rant' with advice for parents

HCA says smaller share of spending going to labor

5 wounded, 2 critically, in Michigan shopping center shooting

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Poland's lawmakers approve a divisive law on Russian influence

Providers still hesitate to prescribe buprenorphine, study finds

leisure time

leisure time

entertainment

hotspot